Mindray Medical International (MR)

Add to Watchlists
Create an Alert
32.40 +0.01  +0.03% NYSE Apr 24, 8:00PM BATS Real time Currency in USD

Mindray Medical International Research and Development Expense (Quarterly):

40.99M for Dec. 31, 2013

View 4,000+ financial data types

View Full Chart

Mindray Medical International Research and Development Expense (Quarterly) Chart

Export Data
Save Image

Mindray Medical International Historical Research and Development Expense (Quarterly) Data

Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Dec. 31, 2013 40.99M
Sept. 30, 2013 31.57M
June 30, 2013 28.57M
March 31, 2013 26.33M
Dec. 31, 2012 32.93M
Sept. 30, 2012 23.22M
June 30, 2012 23.88M
March 31, 2012 24.28M
Dec. 31, 2011 25.59M
Sept. 30, 2011 19.34M
June 30, 2011 18.50M
March 31, 2011 18.59M
Dec. 31, 2010 16.76M
Sept. 30, 2010 14.80M
June 30, 2010 14.32M
March 31, 2010 14.44M
   
Dec. 31, 2009 14.75M
Sept. 30, 2009 14.17M
June 30, 2009 14.72M
March 31, 2009 Upgrade
Dec. 31, 2008 Upgrade
Sept. 30, 2008 Upgrade
June 30, 2008 Upgrade
March 31, 2008 Upgrade
Dec. 31, 2007 Upgrade
Sept. 30, 2007 Upgrade
June 30, 2007 Upgrade
March 31, 2007 Upgrade
Dec. 31, 2006 Upgrade
Sept. 30, 2006 Upgrade
June 30, 2006 Upgrade

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About R&D Expense

R&D expenses are a line item from many companies' income statements.

R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More

Get data for
Advertisement

MR Research and Development Expense (Quarterly) Benchmarks

Companies
Align Technology 13.38M
Cardinal Health
Hologic 48.67M

MR Research and Development Expense (Quarterly) Range, Past 5 Years

Minimum 14.17M Sep 2009
Maximum 40.99M Dec 2013
Average 21.99M
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.